Cell-Tissue-Animal Core Abstract The primary objective of this core is providing primary cell culture and animal models to CHAIN investigators to execute their research projects on the effect of chronic HIV infection/ aging/ cART on brain disease. We have long provided quality primary cells from rodents and humans for Center investigator use. We have newly developed Humanized NSG mouse model and have experience in other rodent models of neuroAIDS. We have multiple techniques and assays enabling the study of both rodent and nonhuman primate models, valuable tools to ask CHAIN and related research questions. The cells and models provided and supported by this Core are essential in many our investigators? neuroAIDS studies. By employing Imaging and Omics Cores, investigators can study progression of disease and molecular determinants of neuropathology in animal models. State of the art methods of analyses are also provided. The general goals of this core is 1) to support the center investigators by providing primary human and rodent blood and brain cells and tissues from animal models of neuroAIDS; 2) to work with CHAIN investigators in the study of animal models of chronic HIV CNS infection, and 3) to provide services/training in situ brain tissue analyses, quantification for SIV/HIV viral RNA, DNA loads, and many other immunological and virological assays required to study CNS disorders.
| Schutt, Charles R; Gendelman, Howard E; Mosley, R Lee (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease. Mol Neurodegener 13:26 |
| Sillman, Brady; Bade, Aditya N; Dash, Prasanta K et al. (2018) Creation of a long-acting nanoformulated dolutegravir. Nat Commun 9:443 |
| Domingo-Almenara, Xavier; Montenegro-Burke, J Rafael; Benton, H Paul et al. (2018) Annotation: A Computational Solution for Streamlining Metabolomics Analysis. Anal Chem 90:480-489 |
| Thomas, Midhun B; Gnanadhas, Divya Prakash; Dash, Prasanta K et al. (2018) Modulating cellular autophagy for controlled antiretroviral drug release. Nanomedicine (Lond) 13:2139-2154 |
| Spooner, Rachel K; Wiesman, Alex I; Mills, Mackenzie S et al. (2018) Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults. Neuroimage Clin 20:85-91 |
| Kiyota, Tomomi; Machhi, Jatin; Lu, Yaman et al. (2018) URMC-099 facilitates amyloid-? clearance in a murine model of Alzheimer's disease. J Neuroinflammation 15:137 |
| Guijas, Carlos; Montenegro-Burke, J Rafael; Warth, Benedikt et al. (2018) Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol 36:316-320 |
| Kevadiya, Bhavesh D; Woldstad, Christopher; Ottemann, Brendan M et al. (2018) Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution. Theranostics 8:256-276 |
| McMillan, JoEllyn; Szlachetka, Adam; Slack, Lara et al. (2018) Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques. Antimicrob Agents Chemother 62: |
| Sillman, Brady; Woldstad, Christopher; Mcmillan, Joellyn et al. (2018) Neuropathogenesis of human immunodeficiency virus infection. Handb Clin Neurol 152:21-40 |
Showing the most recent 10 out of 374 publications
